Ambalal Sarabhai Enterprise Ltd.

BSE: AMBALALSA500009ISIN INE432A01017

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹35.67+0.77 (+2.21%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹49.98
52W low: ₹23.12
Off 52W high: -28.63%
1M return: -5.63%
3M return: -17.24%
6M return: +14.81%
1Y return: +10.47%
20D avg volume: 8,740
50 DMA: ₹39.65
200 DMA: ₹33.37

Key ratios Consolidated

Market cap: ₹273.35 Cr
Current price: ₹35.67
52W high / low: ₹49.98 / ₹23.12
Face value: ₹10.00
P/E: 20.16
P/B: 1.73
EPS (TTM): ₹1.77
Book value / share: ₹20.66
ROE: —
ROCE: 12.10%
Operating margin: —
Net margin: —
Debt / equity: 0.33
Net debt: ₹45.45 Cr
Interest cover: 5.42
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 52.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	43.56	65.49	52.00	44.45	40.34	64.81	45.97	44.70	40.70	54.35	43.11	40.01
	2.03	2.61	2.58	1.62	8.36	1.63	5.61	1.84	2.30	4.79	1.36	2.85
	45.59	68.10	54.58	46.07	48.70	66.45	51.58	46.55	43.00	59.13	44.47	42.87
	41.34	62.26	49.58	45.96	40.75	61.39	48.80	44.40	41.80	49.77	42.70	41.02
	6.90	3.12	5.01	6.18	4.89	5.64	3.99	4.86	5.03	4.50	3.69	4.24
	23.70	34.64	24.24	22.56	18.69	33.60	23.00	21.21	24.15	22.63	18.45	21.16
	7.56	8.88	8.12	8.17	7.38	8.13	7.63	7.72	7.21	7.14	7.29	6.90
	0.98	1.42	0.70	0.96	1.01	0.96	1.14	1.22	0.95	0.90	0.99	0.92
	1.35	1.05	0.96	1.06	0.88	1.02	0.99	1.01	0.98	0.25	1.13	1.14
	9.73	10.99	9.63	9.99	8.21	10.35	11.48	10.64	9.43	10.66	9.44	8.61
	4.25	5.84	5.00	0.11	7.95	5.06	2.78	2.15	1.20	9.37	1.77	1.85
	0.00	0.00	-0.82	0.00	0.00	-7.00	0.00	0.00	0.00	0.00	0.00	0.00
	4.25	5.84	4.18	0.11	7.95	-1.94	2.78	2.15	1.20	9.37	1.77	1.85
	0.70	-0.25	0.72	0.52	-0.29	-1.78	0.70	0.49	0.50	0.73	0.70	0.72
	3.98	6.50	3.64	-0.56	8.22	-0.27	2.23	2.62	0.35	9.02	1.18	1.08
	0.52	0.85	0.40	-0.07	1.07	-0.04	0.29	0.34	0.05	1.18	0.15	0.15
Key metrics
	6.58	8.31	5.84	2.13	9.84	0.04	4.91	4.38	3.13	10.52	3.89	3.91
	15.10%	12.70%	11.20%	4.80%	24.40%	0.10%	10.70%	9.80%	7.70%	19.40%	9.00%	9.80%
	9.10%	9.90%	7.00%	-1.30%	20.40%	-0.40%	4.90%	5.90%	0.90%	16.60%	2.70%	2.70%
	—	4.00%	—	0.70%	—	-0.70%	—	—	—	—	—	—
	8.00%	1.00%	13.10%	-0.60%	-0.90%	19.20%	6.60%	11.70%	—	—	—	—
	-51.60%	2,507.40%	63.20%	-121.40%	2,248.60%	-103.00%	89.00%	142.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	205.50	202.27	196.19	173.57	170.28	196.75
	8.84	15.17	11.38	10.38	12.49	42.02
	214.34	217.44	207.57	183.94	182.77	238.76
	199.14	198.54	196.38	174.58	166.91	175.88
	21.21	19.21	19.52	15.21	13.08	12.73
	105.14	100.13	101.97	83.41	92.16	101.34
	32.73	32.55	30.70	27.70	25.33	25.30
	4.06	4.09	4.26	3.76	2.44	1.70
	4.42	3.94	4.01	3.58	2.75	2.32
	40.34	38.82	41.90	38.54	33.52	31.85
	15.20	18.91	11.19	9.36	15.87	62.89
	-0.82	-0.82	-7.00	0.00	0.00	-15.11
	14.38	18.09	4.19	9.36	15.87	47.77
	1.69	0.70	-0.10	0.97	3.72	6.97
	13.56	17.80	4.93	5.68	11.10	47.22
	1.70	2.32	0.64	0.74	1.45	6.16
Key metrics
	22.86	26.12	12.46	16.70	21.06	51.79
	11.12%	12.90%	6.40%	9.60%	12.40%	26.30%
	6.60%	8.80%	2.50%	3.30%	6.50%	24.00%
	—	12.10%	5.60%	—	—	—
	4.94%	3.10%	13.00%	1.90%	-13.50%	—
	5.94%	261.10%	-13.20%	-48.80%	-76.50%	—
	—	9.16	-20.34	—	—	—
	—	0.75	-3.57	—	—	—
	—	0.33	0.35	—	—	—
	—	45.45	43.70	—	—	—
	—	52.7	32.8	—	—	—
Balance sheet
	—	281.13	270.04	—	—	—
	—	125.03	118.48	—	—	—
	—	6.19	4.89	—	—	—
	—	47.71	44.14	—	—	—
	—	22.23	23.63	—	—	—
	—	9.61	17.90	—	—	—
	—	59.69	62.98	—	—	—
	—	40.73	50.15	—	—	—
	—	98.54	120.40	—	—	—
	—	51.64	48.59	—	—	—
	—	33.99	40.96	—	—	—
	—	17.65	7.63	—	—	—
	—	158.36	139.98	—	—	—
Cash flow
	—	13.40	-17.62	—	—	—
	—	-10.25	13.26	—	—	—
	—	-1.85	-1.53	—	—	—
	—	4.24	2.72	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	0.54	1.52	0.00	0.79	1.64	1.73	1.17	—	1.14	0.98	0.33	0.80
	1.70	3.16	2.89	1.36	8.17	1.39	5.66	6.37	1.88	3.42	1.33	1.97
	2.24	4.67	2.89	2.15	9.81	3.12	6.83	6.37	3.02	4.41	1.65	2.76
	1.96	3.06	1.06	2.53	2.92	3.51	3.87	1.91	2.53	1.74	2.04	2.20
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	1.11	—	—	—
	0.46	1.55	0.00	0.77	1.60	1.70	1.15	—	—	0.96	0.32	0.77
	0.48	0.51	0.48	0.60	0.42	0.66	0.44	0.50	0.50	0.25	0.83	0.69
	0.17	0.17	0.09	0.08	0.07	0.05	0.10	0.09	0.09	0.07	0.06	0.04
	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.03
	0.76	0.88	0.46	1.05	0.79	1.07	2.15	1.29	0.80	0.43	0.78	0.67
	0.29	1.61	1.83	-0.38	6.89	-0.39	2.96	4.46	0.49	2.66	-0.39	0.56
	0.00	0.00	0.00	0.00	0.00	-4.60	5.15	—	—	—	—	—
	0.29	1.61	1.83	-0.38	6.89	-4.99	8.12	4.46	0.49	2.66	-0.39	0.56
	0.26	1.04	0.01	0.00	0.00	-0.02	0.32	0.14	0.03	2.04	0.27	—
	0.03	2.65	1.84	-0.38	6.88	-4.96	8.43	4.31	0.46	4.70	-0.65	0.56
	0.00	0.35	0.24	-0.05	0.90	-0.64	1.10	0.56	0.06	0.62	-0.08	0.07
Key metrics
	0.48	1.80	1.94	-0.28	6.98	-4.92	8.24	4.58	0.61	2.76	-0.30	0.63
	88.90%	118.40%	—	-35.40%	425.60%	-284.40%	704.30%	71.90%	53.50%	281.60%	-90.90%	78.80%
	5.60%	174.30%	—	-48.10%	419.50%	-286.70%	720.50%	67.70%	40.40%	479.60%	-197.00%	70.00%
	—	2.80%	—	-0.50%	—	-10.10%	—	—	—	—	—	—
	-67.10%	-12.10%	-100.00%	-87.60%	43.90%	76.50%	254.50%	696.20%	—	—	—	—
	-99.60%	153.40%	-78.20%	-108.80%	1,395.70%	-205.50%	1,396.90%	669.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	2.85	3.94	4.04	3.81	3.71	0.13
	9.11	15.57	15.29	7.89	10.53	39.53
	11.95	19.52	19.33	11.70	14.24	39.66
	8.61	9.57	11.81	10.89	9.12	6.13
	0.00	0.00	0.00	—	—	—
	2.78	3.93	3.95	3.71	3.65	0.12
	2.07	2.03	2.10	2.04	2.21	2.51
	0.51	0.40	0.34	0.19	0.11	0.25
	0.08	0.09	0.10	0.12	0.14	0.19
	3.15	3.18	5.32	4.83	3.02	3.06
	3.35	9.95	7.53	0.81	5.12	33.53
	0.00	0.00	0.55	—	-0.79	-30.08
	3.35	9.95	8.08	0.81	4.34	3.45
	1.31	-1.04	0.16	1.77	0.23	0.50
	4.14	10.99	8.24	2.58	4.11	2.96
	0.54	1.43	1.08	0.34	0.54	0.39
Key metrics
	3.94	10.44	8.52	1.12	4.59	3.89
	138.25%	265.00%	210.90%	29.40%	123.70%	2,992.30%
	145.26%	278.90%	204.00%	67.70%	110.80%	2,276.90%
	—	16.50%	17.30%	—	—	—
	—	-2.50%	6.00%	2.70%	2,753.80%	—
	-71.76%	33.40%	219.40%	-37.20%	38.90%	—
	—	0.64	-4.18	—	—	—
	—	0.06	-0.50	—	—	—
	—	0.19	0.16	—	—	—
	—	10.81	7.58	—	—	—
	—	-652.2	-1,385.1	—	—	—
Balance sheet
	—	85.79	82.92	—	—	—
	—	41.71	38.62	—	—	—
	—	0.20	0.08	—	—	—
	—	0.42	0.41	—	—	—
	—	0.07	0.00	—	—	—
	—	2.13	2.12	—	—	—
	—	11.95	12.22	—	—	—
	—	7.53	15.74	—	—	—
	—	23.14	34.12	—	—	—
	—	11.01	7.66	—	—	—
	—	8.31	7.66	—	—	—
	—	2.70	0.00	—	—	—
	—	59.48	48.49	—	—	—
Cash flow
	—	0.65	-4.08	—	—	—
	—	-3.02	6.34	—	—	—
	—	2.48	-2.31	—	—	—
	—	0.01	0.10	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +2.03%
Sales CAGR 5Y: —
Profit CAGR 3Y: +38.80%
Profit CAGR 5Y: —
Sales YoY (TTM): -89.09%
Profit YoY (TTM): -71.76%

Consolidated

Sales CAGR 3Y: +5.91%
Sales CAGR 5Y: —
Profit CAGR 3Y: +17.05%
Profit CAGR 5Y: —
Sales YoY (TTM): +4.94%
Profit YoY (TTM): +5.94%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 31.36%

Quarter	September 2026	June 2026
Promoter %	31.36%	31.36%

Holder	Type	Holding	Previous	Change
SARABHAI HOLDINGS PRIVATE LIMITED	Promoter Group	25.77%	25.77%	0.00%
HARYANA CONTAINERS LIMITED	Public	2.28%	2.28%	0.00%
SHARAD KANAYALAL SHAH	Public	1.72%	1.46%	+0.26%
YUDHISTHAR INVESTMENTS PVT LTD IVL	Promoter Group	0.61%	0.61%	0.00%
KOSHALYA INVESTMENTS PVT LTD IVL	Promoter Group	0.60%	0.60%	0.00%
KANDA INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.27%	0.27%	0.00%
VASANTBAHAR INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.26%	0.26%	0.00%
ASHAVARI INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.24%	0.24%	0.00%
TODIRAG HOLDINGS PVT.LTD.(IVL)	Promoter Group	0.24%	0.24%	0.00%
VAISHAKHI INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.24%	0.24%	0.00%
MRIGANK INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.23%	0.23%	0.00%
JONPURI INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.23%	0.23%	0.00%
MADHAVBAG HOLDINGS PVT.LTD.(IVL)	Promoter Group	0.23%	0.23%	0.00%
RAJKA DESIGNS PRIVATE LIMITED	Promoter Group	0.22%	0.22%	0.00%
BILAWAL INVESTMENTS PVT.LTD.(IVL)	Promoter Group	0.21%	0.21%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Ambalal Sarabhai Enterprise Ltd.	273	35.67	20.16	12.10%	+4.94% TTM	+5.94% TTM	+10.47%

Filings & corporate actions

Recent announcements

Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited (Standalone ....28 Oct 2026 · Board Meeting / Board Meeting
We hereby submit Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018. Kindly take the same on your records.6 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We hereby submit intimation of Closure of Trading Window. Kindly take the same on your records.25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
We hereby submit Newspaper publication. Kindly take the same on your records.14 Aug 2026 · Company Update / Newspaper Publication
We hereby submit Quarterly Snapshot (Q26 Vs. Q25). Kindly take the same on your records.13 Aug 2026 · Company Update / General
We hereby submit unaudited financial results (standalone and consolidated) for the quarter ended 30.06.2026 along with limited review report from auditors thereon. Kindly take the same ....12 Aug 2026 · Result / Financial Results
We hereby submit outcome of Board Meeting held on 12.08.2026. Kindly take the same on your records.12 Aug 2026 · Board Meeting / Outcome of Board Meeting
We here by submit a Clarification on Price Movement. Kindly take the same on your records.6 Aug 2026 · Company Update / General
The Exchange has sought clarification from Ambalal Sarabhai Enterprises Ltd on August 5, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....5 Aug 2026 · Company Update / Clarification
We hereby submit revised date of plant visit and other details. Kindly take the same on your records.5 Aug 2026 · Company Update / General
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial ....5 Aug 2026 · Board Meeting / Board Meeting
We hereby submit Scrutinizer''s Report. Kindly take the same on your records.31 Jul 2026 · AGM/EGM / AGM
We hereby submit outcome of the 48th Annual General Meeting. Kindly take the same on your records.30 Jul 2026 · AGM/EGM / AGM
We hereby submit newspaper publication for AGM. Kindly take the same on your records.13 Jul 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that subsequent to the submission of the Annual Report for ....8 Jul 2026 · Others / Reg. 34 (1) Annual Report
We hereby submit Annual Report for 48th AGM of the Company to be held on 30.07.2026. Kindly take the same on your records.7 Jul 2026 · Others / Reg. 34 (1) Annual Report
We hereby submit Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018. Kindly take note of the same.3 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We hereby submit intimation of closure of Trading Window. Kindly take the same on your records.29 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
We hereby submit Annual Secretarial Compliance Report for FY 2025-26. Kindly take the same on your records.27 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
We hereby submit clippings of Newspaper. Kindly take the same on your records.24 May 2026 · Company Update / Newspaper Publication
We hereby submit details for Annual General Meeting of the Company. Kindly take the same on your records.21 May 2026 · AGM/EGM / AGM
We hereby Submit details of re-appointments as per the attached file. Kindly take the same on your records.21 May 2026 · Company Update / Change in Management
We here by submit Financial Results (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026 along with Auditors Report thereon. Kindly take the same on your records.21 May 2026 · Result / Financial Results
Outcome of Board Meeting21 May 2026 · Board Meeting / Outcome of Board Meeting
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Audited Financial ....14 May 2026 · Board Meeting / Board Meeting
Intimation regarding change in Branch Address of RTA24 Apr 2026 · Company Update / General
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....21 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....21 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
We hereby submit Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018. Kindly take the same on your records.9 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
We here by submit Newspaper publication under Regulation 30 and 47 of SEBI (LODR) Regulations, 2015. Kindly take the same on your records.16 Feb 2026 · Company Update / Newspaper Publication
We hereby submit the Outcome of Board Meeting held on 12.02.2026. Kindly take the same on your records.12 Feb 2026 · Board Meeting / Outcome of Board Meeting
We hereby submit financial Result (Standalone and Consolidated) for the quarter and nine months ended 31.12.2025 along with Limited Review Report of Auditors thereon. Kindly take the ....12 Feb 2026 · Result / Financial Results
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Unaudited Financial ....4 Feb 2026 · Board Meeting / Board Meeting
We hereby submit herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018. Kindly take the same on your records.5 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading Window.31 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
We hereby submit newspaper publication under regulation 30 and 47 of SEBI (LODR) Regulation, 2015. Kindly take the same on your records.14 Nov 2025 · Company Update / Newspaper Publication
We hereby submit Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended 30.09.2025 along with Limited Review Report of Auditors thereon. Kindly take ....12 Nov 2025 · Result / Financial Results
We hereby submit outcome of the Board Meeting held on 12.11.2025. Kindly take the same on your records.12 Nov 2025 · Board Meeting / Outcome of Board Meeting
We hereby submit announcement under Regulation 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on your records.6 Nov 2025 · Company Update / General

Board meetings

5 Nov 2026 Board Meeting - Financial Results
12 Aug 2026 Board Meeting - Financial Results